BDSX
Biodesix Inc
NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.32
-0.97% today
Updated 2026-05-08
Market cap
$113.91M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-4.75
Dividend yield
—
52W range
$3 – $20
Volume
0.1M
Biodesix Inc (BDSX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-36.2%
Last 4 quarters
Revenue YoY growth
+42.3%
Most recent quarter
EPS YoY growth
-912.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+16.1%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+33.1%
2026-05-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-05-05 | $-0.81 | +26.1% | $11.27 | $15.00 | +33.1% |
| 2026-02-27 | $-0.49 | +43.4% | $14.22 | $15.75 | +10.8% |
| 2025-10-30 | $-1.16 | -1856.2% | $6.54 | $6.83 | +4.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-1.10 | $-0.81 | +26.1% | $25.55M | +42.3% |
| 2025-12-31 | $-0.87 | $-0.49 | +43.4% | $28.75M | +40.8% |
| 2025-09-30 | $-0.06 | $-1.16 | -1856.2% | $21.77M | +19.9% |
| 2025-06-30 | $-0.07 | $-0.08 | -14.3% | $20.02M | +11.7% |
| 2025-03-31 | $-0.07 | $-0.08 | -14.3% | $17.96M | +21.2% |
| 2024-12-31 | $-0.07 | $-0.06 | +10.0% | $20.43M | +39.3% |
| 2024-09-30 | $-0.07 | $-0.07 | +0.0% | $18.15M | +34.5% |
| 2024-06-30 | $-0.09 | $-0.08 | +11.1% | $17.93M | — |
| 2024-03-31 | $-0.14 | $-0.14 | +0.0% | $14.82M | — |
| 2023-12-31 | $-0.11 | $-0.10 | +9.1% | $14.67M | — |
| 2023-09-30 | $-0.15 | $-0.14 | +6.7% | $13.49M | — |
Frequently asked questions
Has Biodesix Inc beaten earnings estimates?
Biodesix Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -36.2% over the last 4 quarters.
How does BDSX stock react to earnings?
BDSX stock has moved an average of +16.1% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Biodesix Inc's revenue growth rate?
Biodesix Inc reported year-over-year revenue growth of +42.3% in its most recent quarter, with EPS growing -912.5% year-over-year.